Skip to main content Back to Top
Advertisement

11/7/2016

Desmopressin Injection

Products Affected - Description

    • DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00075-2451-01
    • DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00075-2451-53
    • Desmopressin Acetate injection, Caraco, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 62756-0529-40
    • Desmopressin Acetate injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-5030-01
    • Desmopressin Acetate injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-5040-01
    • Desmopressin Acetate injection, Pfizer, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00409-2265-01
    • Desmopressin Acetate injection, Teva, 4 mcg/mL, 1 mL vial, 10 count, NDC 00703-5051-03
    • Desmopressin Acetate injection, Teva, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00703-5054-01

Reason for the Shortage

    • Teva and Hospira have desmopressin injection on shortage due to manufacturing delays.
    • Ferring divested generic desmopressin to Amring Pharmaceuticals in January 2016.
    • Caraco will not provide availability information at this time.

Available Products

    • DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-2200-00
    • DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-2300-00
    • Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 1 mL ampule, 10 count, NDC 69918-0899-10
    • Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 10 mL vial, 1 count, NDC 69918-0901-10

Estimated Resupply Dates

    • Hospira has desmopressin 4 mcg/mL 1 mL ampules on back order and the company cannot estimate a release date.
    • Teva has desmopressin 4 mcg/mL 1 mL and 10 mL vials on long-term back order and the company estimates a release date in fourth quarter of 2017.
    • Amring and Ferring have had product available for several months and have been supplying the market.

Updated

Updated November 7, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 7, 2010 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins